跳至主要内容
临床试验/CTRI/2025/02/080764
CTRI/2025/02/080764尚未招募3 期

Evaluation of perioperative outcomes with enhanced recovery after surgery alone versus combined enhanced recovery after surgery and prehabilitation in patients undergoing surgery for advanced ovarian cancer:- An open labelled randomised controlled trial

Pooja1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年2月21日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
1. Functional capacity assessment using cardiopulmonary testing by six minute

研究概览

简要总结

Aim

To compare the efficacy of a robust prehabilitation program in combination with

enhanced recovery after surgery (ERAS) on functional parameters and perioperative

outcomes versus enhanced recovery after surgery (ERAS) alone in women

undergoing surgery for advanced ovarian cancer

Objectives

Primary objective

a) To compare cardiopulmonary function, nutritional parameters and

psychological status before and after implementation of prehabilitation

program with enhanced recovery after surgery (ERAS) versus enhanced

recovery after surgery (ERAS) alone

b) To assess and compare perioperative outcomes in both groups

Secondary objectives

a) Adherence to prehabilitation program

b) To study adverse events related to prehabilitation

Hypothesis

Addition of prehabilitation to enhanced recovery after surgery (ERAS) will improve

perioperative outcomes in women undergoing surgery for advanced ovarian cancer.

Methodology

All patients presenting with advanced ovarian cancer presenting to our institution

after informed consent and meeting inclusion criteria will be included in the study. All

eligible patients planned for primary upfront or interval debulking surgery after

chemotherapy for advanced ovarian cancer will be recruited to the study. For upfront

surgery patients will be hospitalised for work-up and optimisation of general condition

which will take around 3 weeks and interventions will be administered under direct

supervision .Patients receiving neoadjuvant chemotherapy will take around 3

months .Initial hospitalisation will be done for work up and treatment planning. During

this period they will be taught prehabilitation measures. Thereafter this will be

recorded in a chart (Annexure 1). Randomization will be done using simple random

number table to intervention and control groups (group 1 & 2) in a 1:1 ratio.

Allocation to each group will be done using block randomisation in which A group will

represent patients undergoing ERAS and prehabilitation and B group will represent

patients undergoing only for ERAS. The intervention group will have ERAS plus

prehabilitation while control group will undergo ERAS as part of standard

preoperative protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
Female

入选标准

  • Advanced ovarian cancer for upfront surgery or after NACT
  • Preoperative schedule that allows from at least 3 weeks for upfront surgery and upto three months for interval debulking surgery
  • Treatment naive patients
  • Eastern Cooperative Oncology Group Performance Status of up to 2.

排除标准

  • Significant comorbidities or limitation of locomotion that prohibit the patient to perform prehabilitation activities
  • Emergency surgeries
  • Surgeries by minimally invasive approach (laparoscopy or robotics)
  • Patients suffering from depression and major psychiatric illness.

结局指标

主要结局

1. Functional capacity assessment using cardiopulmonary testing by six minute

时间窗: 3 weeks to 3 months

walk test (6 MWT) and pulmonary function tests using spirometry.

时间窗: 3 weeks to 3 months

2. Nutritional assessment by serum albumin levels, body mass index, and hand

时间窗: 3 weeks to 3 months

grip strength test

时间窗: 3 weeks to 3 months

3. Quality of life assessment using European Organization for Research and

时间窗: 3 weeks to 3 months

Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-

时间窗: 3 weeks to 3 months

C30)

时间窗: 3 weeks to 3 months

4. To measure intraoperative anaesthetic parameters - peak pressure, plateau

时间窗: 3 weeks to 3 months

pressure, lactate levels, tidal volume, temperature, urine output, ionotropic

时间窗: 3 weeks to 3 months

requirement, cardiac ejection fraction, problems during weaning off

时间窗: 3 weeks to 3 months

(extubation failure and immediate need for re-intubation and post extubation

时间窗: 3 weeks to 3 months

stridor)

时间窗: 3 weeks to 3 months

5. To measure intraoperative surgical outcomes - duration of surgery in minutes ,

时间窗: 3 weeks to 3 months

blood loss, transfusion of blood and blood products, cytoreductive outcomes,

时间窗: 3 weeks to 3 months

surgical complexity score.

时间窗: 3 weeks to 3 months

次要结局

  • 1. Proportion of patients with adherence to prehabilitation program as measured(by asking them to maintain and enter daily records of exercises, diet and)

研究者

发起方
Pooja
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Pooja

All India Institute of Medical Sciences, Rishikesh

研究点 (1)

Loading locations...

相似试验